Followers | 82 |
Posts | 5373 |
Boards Moderated | 0 |
Alias Born | 11/29/2016 |
Friday, December 15, 2017 3:46:04 PM
ViaDerma Investor Relations <info@viadermalicensing.com>
Today, 1:40 PMYou
Thanks Karl. The increase was to the authorized to allow for future raising of funds given the anticipated large increase in production we expect to undertake.
Thanks Again
---
ViaDerma Investor Relations
310-734-6111
On 2017-12-15 00:05, K==== M======== wrote:
>
> ViaDerma Investor Relations
>
>
>
> I want to again thank you for your speedy and appropriate responses. We do have great concern about the share count increases and we hope it be over with. Perhaps a slight company share buyback, once you really start to rock and roll, will get your pps into the big leagues.
>
>
>
> Best regards
>
>
>
> Karl
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM